<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: To report the efficacy of intravitreal bevacizumab injection in treatment of macular <z:hpo ids='HP_0000969'>edema</z:hpo> in a case of optic disc <z:hpo ids='HP_0002633'>vasculitis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Design: Retrospective case review </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: A patient diagnosed with macular <z:hpo ids='HP_0000969'>edema</z:hpo> due to optic disc <z:hpo ids='HP_0002633'>vasculitis</z:hpo> was treated with intravitreal bevacizumab injection </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: One week after injection, fundus appearance dramatically improved and macular <z:hpo ids='HP_0000969'>edema</z:hpo> regressed </plain></SENT>
<SENT sid="4" pm="."><plain>The patient was followed up for 1 year after injection and there was no recurrence of macular <z:hpo ids='HP_0000969'>edema</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>CONCLUSIONS: This case suggests that intravitreal bevacizumab treatment might be effective in the management of macular <z:hpo ids='HP_0000969'>edema</z:hpo> in patients with optic disc <z:hpo ids='HP_0002633'>vasculitis</z:hpo> </plain></SENT>
</text></document>